EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1

Mehrshad Fekri, Azam Bolhassani iD, Monireh Movahedi, Fereshteh Rahmati

PLOS One · 2025

DOI: 10.1371/journal.pone.0336042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mehrshad Fekri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: HSP70 Heat-Shock Proteins, Interleukin-15, Vaccines, DNA, HIV-1. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-15 serves as a potent adjuvant that can enhance T cell-directed vaccine responses. Moreover, heat shock proteins (HSPs) have been used as potent adjuvants in immunotherapy of tumors and infectious diseases, as well as in vaccine development. In this study, we evaluated the ability of IL-15 and HSP70 fragments (C-terminal (CT)-Hsp70 and N-terminal (NT)-Hsp70) to act as adjuvants for enhancing the immunostimulatory effects of a HIV-1 DNA vaccine candidate against single-cycle replicable (SCR) HIV-1. These adjuvants were administered individually and in combination with the HIV-1 Nef antigen candidate in BALB/c mice. The Nef, CT-Hsp70-Nef, NT-Hsp70-Nef and IL-15 genes were individually subcloned into the eukaryotic expression vector pVAX-1. Our results showed that the linkage of the CT-Hsp70 or the NT-Hsp70 gene to the Nef gene could significantly increase immune responses compared to the Nef gene alone ( p < 0.05). Moreover, the combination of pVAX-IL-15 with DNA constructs could significantly augment immune responses. Indeed, the combination of pVAX-IL-15 with pVAX-CT-Hsp70-Nef or pVAX-NT-Hsp70-Nef could substantially increase immune responses compared to pVAX-Nef combined with pVAX-IL-15 ( p < 0.05). Notably, the pVAX-CT-Hsp70-Nef construct, alone or combined with pVAX-IL-15, could significantly enhance immune responses to a greater extent than pVAX-NT-Hsp70-Nef with or without pVAX-IL-15 ( p < 0.05). In addition, we demonstrated that the highest secretion of total IgG antibody, interferon (IFN)- γ , and granzyme B was observed in the group receiving pVAX-CT-Hsp70-Nef combined with pVAX-IL-15, suggesting a shift in immune responses toward T helper type 1 (Th1) and cytotoxic T lymphocyte (CTL) activities. Furthermore, the pVAX-CT-Hsp70-Nef combined with pVAX-IL-15 regimen could maintain IFN-γ secretion after infection of mouse splenocytes with SCR HIV-1. Overall, our findings indicated that the concurrent use of two adjuvants—CT-Hsp70 and IL-15—effectively enhances antigen-specific immune responses. This regimen could be utilized as a vaccine candidate for boosting effective immune responses against HIV-1 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP70 Heat-Shock ProteinsInterleukin-15Vaccines, DNAHIV-1AIDS VaccinesHIV InfectionsAnimalsMiceMice, Inbred BALB CAdjuvants, Immunologicnef Gene Products, Human Immunodeficiency VirusFemaleHumans

Substanzen

HSP70 Heat-Shock ProteinsInterleukin-15Vaccines, DNAAIDS VaccinesAdjuvants, Immunologicnef Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Department of Biochemistry, NT.C., Islamic Azad University, Tehran, Iran.
  • Department of Hepatitis, AIDS and Blood-borne Diseases, Pasteur Institute of Iran, Tehran, Iran.

ORCID-Profile: Azam Bolhassani

Zitieren

APA

Fekri, M., Bolhassani, A., Movahedi, M., & Rahmati, F. (2025). Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1. PLOS One. https://doi.org/10.1371/journal.pone.0336042

Vancouver

Fekri M, Bolhassani A, Movahedi M, Rahmati F. Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1. PLOS One. 2025. doi:10.1371/journal.pone.0336042

BibTeX
@article{Fekri2025,
  author = {Fekri, Mehrshad and Bolhassani, Azam and Movahedi, Monireh and Rahmati, Fereshteh},
  title = {Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0336042}
}
Kostenlos starten →